Your browser doesn't support javascript.
loading
Enhancement of therapeutic potential of mesenchymal stem cell by IGF-1 delivery in PLGA microspheres for tissue regeneration.
Ge, Min; Sun, Li; Wang, Defeng; Hei, Chunchao; Huang, Tingjuan; Xu, Zhongxin; Shuai, Qizhi.
Afiliação
  • Ge M; School of Clinical Medicine, Medical College, Affiliated Hospital of Hebei University of Engineering, Hebei University of Engineering, Handan, 056038, China.
  • Sun L; School of Clinical Medicine, Medical College, Affiliated Hospital of Hebei University of Engineering, Hebei University of Engineering, Handan, 056038, China.
  • Wang D; School of Clinical Medicine, Medical College, Affiliated Hospital of Hebei University of Engineering, Hebei University of Engineering, Handan, 056038, China.
  • Hei C; School of Clinical Medicine, Medical College, Affiliated Hospital of Hebei University of Engineering, Hebei University of Engineering, Handan, 056038, China.
  • Huang T; Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan, 030001, China.
  • Xu Z; School of Clinical Medicine, Medical College, Affiliated Hospital of Hebei University of Engineering, Hebei University of Engineering, Handan, 056038, China.
  • Shuai Q; Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan, 030001, China.
Regen Ther ; 27: 112-119, 2024 Dec.
Article em En | MEDLINE | ID: mdl-38550913
ABSTRACT
The use of stem cell-based treatment systems is prevalent in regenerative medicine. To enhance the regenerative capabilities of stem cells, growth factors are typically incorporated into the treatment system. Nonetheless, traditional hydrogel-encapsulated or heparinized scaffolds that bind factors have limitations. In this study, we prepared a biomaterial strategy using uniform poly(lactic-co-glycolic) acid (PLGA) microspheres (uPLGA-Ms) fabricated by microfluidic to sustain delivery of insulin-like growth factor 1 (IGF-1), a critical protein for hMSCs biological functions. The uPLGA-Ms loaded IGF-1 were highly monodispersed through precise manipulation of the flow rate of the two-phase of the flow-focusing microchannle. The results showed that the uPLGA-Ms stabilize IGF-1 and provide a more efficient sustained delivery and cost-effective of growth factor. Gene expression analysis demonstrated the uPLGA delivery of IGF-1 results in a (enhanced) supported hMSCs expansion, survival, stemness, and secretion abilities comparable with the conventional soluble IGF-1 group. In summary, this material-based strategy to stabilize and sustain delivery of growth factor has broad potential to regeneration of various tissues and organs.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article